Although age is thought to correlate with the prognosis of glioma patients, the most appropriate age-group classification standard to evaluate prognosis had not been fully studied. This study aimed to investigate the influence of age-group classification standards on the prognosis of patients with high-grade hemispheric glioma (HGG). This retrospective study of 125 HGG patients used three different classification standards of age-groups (≤50 and N 50 years old, ≤60 and N 60 years old, ≤45 and 45-65 and ≥65 years old) to evaluate the impact of age on prognosis. The primary end-point was overall survival (OS). The Kaplan-Meier method was applied for univariate analysis and Cox proportional hazards model for multivariate analysis. Univariate analysis showed a significant correlation between OS and all three classification standards of age-groups as well as between OS and pathological grade, gender, location of glioma, and regular chemotherapy and radiotherapy treatment. Multivariate analysis showed that the only independent predictors of OS were classification standard of age-groups ≤50 and N50 years old, pathological grade and regular chemotherapy. In summary, the most appropriate classification standard of age-groups as an independent prognostic factor was ≤50 and N 50 years old. Pathological grade and chemotherapy were also independent predictors of OS in post-operative HGG patients.
Introduction
Gliomas are the most frequently occurring primary tumors of the central nervous system [1] . Grade III and grade IV tumors, which are called high-grade gliomas (HGGs) have a poor prognosis and no effective therapeutic strategies [2] . Despite tremendous progress in this field over the past decade, the median survival in patients with glioblastoma multiforme (GBM) is approximately 1 year [3] . The current standard of care for HGGs includes a combination of surgery and adjuvant focal, external beam radiation, and is largely palliative in nature [4] . Some challenges with the current standard of care therapy include the findings that sublethal doses of radiation promoted the migration of glioma cells, leading to locoregional relapses [5] . Addition of a daily oral dose of the chemotherapeutic agent, temozolamide (TMZ) significantly improved the survival rate from 6%-10% compared with patients treated with adjuvant radiotherapy alone [6, 7] . However, development of drug resistance and toxicity is the major drawbacks with this chemotherapy regimen [8] . Moreover, tumor recurrence is almost inevitable even after a therapeutic strategy using a combination of the most extensive tumor resection possible along with post-operative adjuvant radiochemotherapy [3, [9] [10] [11] .
A number of studies have investigated the factors predicting tumor recurrence and survival in HGG patients. Some molecular markers which have been used for prognostic purposes as well as to identify glioma subtypes include 1p/19q chromosomal codeletion, isocitrate dehydrogenase (IDH) mutations, methylation of O-6-methylguanine-DNA-methyltransferase promoter (MGMT), amplification of the epidermal growth factor receptor (EGFR) gene, and overexpression of vascular endothelial growth factor A (VEGF-A) [12] [13] [14] . Additionally, age, histopathology, molecular pathology and imaging, the extent of tumor resection and Karnofsky Performance Scale (KPS) scores have been shown to be correlated with prognosis [15] [16] [17] .
The median age of onset of HGG is 64 years old and patients N70 years old comprise almost 20% of all newly diagnosed glioblastoma cases in the United States [18] . Elderly patients are more prone to complications, their ability to tolerate surgery, chemotherapy and radiotherapy is inferior to that of young patients, and they are generally excluded from most clinical trials. Elderly patients have also been shown to express higher levels of VEGF compared with younger patients, and this has been suggested to contribute to the fact that they have a worse prognosis than young patients [19] . A number of studies have evaluated age as a prognostic factor. A single institutional review of 70 patients with intracranial anaplastic oligodendroglioma showed that patients b50 years old had a significantly longer median survival compared with patients N 50 years old [15] . Other studies also demonstrated that in addition to KPS scores, extent of surgery, and histological characteristics, age was a significant prognostic factor [20, 16, 21] . In contrast, data from some studies suggested that age was not a prognostic factor in glioma patients [17, 22] .
Since there was a significant variation in the age classification standards used in the different studies, we hypothesized that the conflicting data from previous studies may be due to differences in the age classification standards. In this study, we aimed to evaluate the influence of different classification standards of age-groups on the prognosis of patients with high-grade hemispheric glioma.
Patients and methods

Clinical data
This study gathered clinical and imaging data from a total of 125 patients with high-grade hemispheric glioma who received surgery and then were pathologically verified at the Division of Neurosurgery of the First Affiliated Hospital of Fujian Medical University between June 2002 and June 2012. The extent of resection was determined using post-operative enhanced MRI within 3 days of surgery. The inclusion criteria are as follows: 1) presence of fully-resected high-grade hemispheric glioma under the operating microscope, 2) availability of clear radio-chemotherapy data and follow-up data, and 3) availability of clear pathological data. The exclusion criteria are as follows: 1) presence of infratentorial glioma, brain glioma or WHO grade I, II glioma, 2) absence of histopathological data and 3) absence of follow-up data. Patients who underwent partial resection or biopsy were also excluded (partial resection is indicated by the presence of an enhancing lesion which occupies more than 80% of the surgical cavity). Most of the study patients received post-operative radio-chemotherapy. The chemotherapy treatment plan included ≥4 cycles of temozolomide (TMZ; 150 mg/M2KOF/day); radiation therapy, with a single dose of 2 Gy up to a total dose of 54-58 Gy was concomitantly administered after the second cycle of chemotherapy. The irradiated area covered the operating region plus a safety margin of 2 cm. Chemotherapy was carried out at our clinical center, while radiotherapy was performed at different clinical centers. The accumulated numbers of irradiation ranged from 0 to 30, and a single irradiation dose to an individual ranged from 0 to 2.65 Gy. Pathological grades were based on the 2007 WHO classification standard of brain tumors [23] .
Classification of patients by age was based on three different methods: (1) ≤50 or N50 age-groups as previously described by Yang et al. [15] ; (2) ≤60 or 60 age-groups as previously described by Allahdini et al. [17] ; and (3) ≤ 45, 45-65, or ≥ 65 age-groups as previously described by Lacroix et al. [24] .
The primary outcome was overall survival (OS), which was defined as the time period from the first surgery until death or until the final follow-up visit. The study was terminated on June 1st, 2012. A total of 39 patients were still alive at the end of follow-up and 86 patients had died (28 grade III cases, 58 grade IV cases).
Informed consent was obtained from all study patients and the study was approved by the medical ethics committee of the Fujian Medical University.
Statistical analyses
Categorical variables were shown as number and percent, while continuous variables were shown as mean and standard deviation (SD). Subjects were followed-up from the time of surgical operation until death or until the last follow-up. Kaplan-Meier survival analyses were used to estimate the probability of survival with different age-groups as cut-off points. Log-rank tests were performed to compare survival rates among age-groups. Cox proportional hazard regression models were performed to calculate hazard ratio (HR) with 95% confidence interval (CI) for risk of death. In order to identify significant effects of each variable with multiple categories, tests of global null hypothesis by likelihood ratio tests were further used by comparing intercept-only model to the model with the variable being tested.
The multivariate Cox regression model included significant variables identified by univariate analysis, except for age-groups. Subsequently, a backward selection procedure was performed; variables with p-values of less than 0.05 were included in Model I. After the multivariate Cox regression model (Model I) was constructed, three separate models were created by applying age-groups with different cut-off points. These included Model II: ≤45 years, 46-64 years, and ≥65 years; Model III: ≤50 years and N50 years; and Model IV: ≤60 years and N 60 years. The Akaike information criterion (AIC) was calculated to determine the best cut-off point of age among three multivariate models. The model with the lowest AIC value was considered as the best model. All statistical analyses were performed with SAS software version 9.2 (SAS Institute Inc., Cary, NC). A two-tailed p b 0.05 indicated statistical significance.
Results
The study population comprised 78 males (62.4%) and 47 (37.6%) females. The ratio of males to females was 1.66:1. The age range of the study subjects was 16-78 and the mean age was 48.1 years (SD = 14.6 years). Analysis of age of the study patients showed that 43.2% of the subjects was under 45 years old, 47.2% was N50 years old, and 21.6% of subjects was N60 years old ( ) ( Table 1 ). The mean follow-up time was 23.2 months (SD = 21.9 months). A total of 86 subjects (68.8%) died during the study period. The median survival time was 19 months and the one-year and two-year survival rates were 64.8% and 40.0%, respectively (data not shown). Survival rates were analyzed in the different age-groups using Kaplan-Meier curves (Fig. 1) . Regardless of the definition of age groups, results of log-rank test consistently showed that patients in the older age-group had significantly lower survival rates compared with patients in the younger age-groups (all p b 0.001). Kaplan-Meier survival curves were also plotted for demographic and clinical characteristics. We showed that survival outcomes were better in patients who were female, had received regular chemotherapy and radiotherapy, had lower grade of tumor based on WHO classification, or had lobar-involved glioma (Fig. S1) .
We analyzed the effect of age on OS using multivariate Cox regression models of the age groups with different cut-off points. Since gender and radiotherapy were not significant after backward selection procedure was performed, we excluded them from our multivariate analysis. Hazard ratio was used as the index of risk of death, defined by the ratio of risk of death in older patients to that in younger patients. When age was not considered in the analysis (Model I), we showed that regular chemotherapy (HR = 0.45 and 95% CI = 0.25-0.82, p = 0.009) and a higher Karnofsky Performance scale (KPS) score were both associated with a decreased risk of death (HR = 0.97 and 95% CI = 0.96-0.99, p b 0.001). Additionally, subjects with grade IV gliomas of the cerebral hemisphere had a higher risk of death compared with those with a lower grade (HR = 3.71 and 95% CI = 2.26-6.10) ( Table 2) .
Models II, III, and IV were constructed using three definitions of age respectively. After taking clinical characteristics into consideration, we showed that a higher age was significantly associated with a higher risk of death, regardless of the definition of age (all p b 0.05). Older patients had a two-to three-fold higher risk of death compared with younger patients across all three age-groups (age group 1: HR = 2.11 for 46-64 years vs. ≤45 years and 3.28 for ≥65 years vs. ≤45 years; age group 2: HR = 2.74, 95% CI = 1.72-4.35; age group 3: HR = 2.57, 95% CI = 1.53-4.33). Based on our statistical data from each model, Model III was the best fitted model with the least AIC value (AIC = 669.102) ( Table 2) .
Post-hoc power was calculated. We showed that given the hazard ratio, sample size, follow-up period and median survival time with alpha level at 0.05, the power was 0.88, 0.92 and 0.76 for age groups 1, 2 and 3, respectively.
Discussion
In this study, we evaluated the influence of different classification standards of age-groups on the prognosis of patients with high-grade hemispheric glioma. We used a stringent statistical analysis to fit all three age-groups into different classification models. (A) Age group 1: ≤ 45 years, 46-64 years, and ≥ 65 years; (B) age group 2: ≤ 50 years and N50 years; and (C) age group 3: ≤ 60 years and N 60 years. We showed that the most appropriate classification standard of agegroups as an independent prognostic factor was age-group 2, and 50 years of age was the best cut-off point. We also showed that pathological grade and regular chemotherapy regimen were independent factors influencing OS of post-operative HGG patients.
A number of studies have investigated factors predicting OS in HGG patients, since OS effectively reflects the prognosis of these patients. There are conflicting data on the influence of gender on the prognosis of HGG. Although some studies showed that gender was not a prognostic factor, other data showed that gender had an impact on prognosis, but was significant only in univariate analyses [25] [26] [27] [28] . A recent study used univariate as well as multivariate analysis and identified female gender as a significant positive prognostic factor of OS in 64 HGG patients who received reirradiation at progression [29] . However, it is important to validate their data using a larger sample size. In the present study, we used univariate analysis to show that females had a longer median OS compared with males. However, gender was not a prognostic factor in our multivariate analysis. We suggest that if future studies confirm a correlation between gender and prognosis of HGG, it will be important to unravel the impact of hormones on the tumorigenesis of glioma.
Using univariate and multivariate analyses, our present study showed that higher pathological grade was an independent negative prognostic factor for HGG patients. Our data were consistent with previous reports which identified pathological grade as an independent prognostic factor associated with OS in HGG patients [30, 31] . Although radiation therapy has previously shown to have a relatively small impact on OS of HGG patients [15] , and there are conflicting data on the effects of post-operative adjuvant radiochemotherapy [6, 32] , in the Fig. 1 . Kaplan-Meier survival curves according to age-groups (A) age group 1 classification: ≤45 years, 46-64 years, and ≥65 years; (B) age group 2 classification: ≤50 years and N50 years; and (C) age group 3 classification: ≤60 years and N60 years. Log-rank tests were performed to compare survival rates among age-groups. present study, radiation therapy was a prognostic factor associated with significantly longer OS in our univariate, but not multivariate analysis. We suggest that our data on the significance of radiation therapy were not consistent with the results from the EORTC studies possibly because our study did not use the HGG grade III and grade IV classification system based on the WHO criteria, It could also be because radiotherapy of individual patients was performed at different medical centers, resulting in a lack of uniform radiotherapy standards, and varying accumulated doses for individual patients. It will be interesting to reevaluate the prognostic value of a uniform radiotherapy regimen in these patients. The effect of adjuvant chemotherapy also remains unclear. Some studies showed that adjuvant chemotherapy was significantly correlated with prognosis [15, 17] , while other studies did not observe this correlation [29, 30] . Our present study demonstrated that chemotherapy was a prognostic factor both in univariate and multivariate analyses. Patients who received regular chemotherapy had significantly longer OS rates compared with those who received irregular or no chemotherapy, even those who had received a full resection of their high-grade glioma. Our data strongly suggested that HGG patients should receive post-operative radiotherapy as well as chemotherapy to maximize OS rates.
An early study suggesting that age was a prognostic factor for HGG [33] was validated by other clinical studies which reported that age was a significant independent prognostic factor for glioma following surgery [15, 16, 21, 20] . However, there are conflicting data which show that age is not a prognostic factor [17, 22] . These conflicting data can be explained by the fact that the classification standards of age varied between the different reports and the bias of age distribution were very high, making it impossible to make objective conclusions. To the best of our knowledge, there are no reports which have determined the most appropriate standard of age-group classification to evaluate prognosis in HGG patients. In our present study, we adopted three different age classification standards and performed a univariate analysis to show that all three classification standards served as prognostic factors. Our multivariate analysis showed that a higher age was significantly associated with a higher risk of death. However, it is important to note that the bias in the number of cases in age groups 1 and 3 was high, while the groups classified as b50 and N 50 had similar numbers of patients, suggesting that the impact of age bias can be excluded for age group 2, and that our data for age group 2 were relatively objective. The major limitations of our present study were the small sample size and the fact that it was retrospective. We also did not differentiate the different subgroups within the HGG groups based on histology. Another limitation of this study was that we did not include patients who underwent re-operation for recurrence. It is important to further validate our results with multicenter prospective studies on a large sample size.
In summary, we showed that age groups classified by age 50, chemotherapy, and pathological grade are independent factors influencing OS in patients with HGG. Our data have important implications for the clinical management of patients with high-grade hemispheric glioma.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.jns.2015.06.036. Abbreviation: HR = adjusted hazard ratio; CI = confidence interval; AIC = Akaike information criterion. a Gender, chemotherapy, radiotherapy, grade and Karnofsky Performance Scale were entered initially. After backward selection procedure was performed, gender and radiotherapy were excluded. b HR and 95% CI were calculated by Cox regression analysis.
